Thursday, 5 April 2018

J&J, Imerys must pay $37 million in case over talc cancer risks: jury

(Reuters) - Johnson & Johnson and Imerys SA must pay at least $37 million in a lawsuit claiming a man developed cancer due to his exposure to asbestos in talc-based products including Johnson's Baby Powder, a New Jersey state court jury said on Thursday.


No comments:

Post a Comment